DLX5, a gene crucial for embryonic development, promotes cancer by activating the expression of the known oncogene, MYC, according to researchers. Since the DLX5 gene is inactive in normal adults, it may be an ideal target for future anti-cancer drugs, they reason.
Full article >>
Wednesday, August 5, 2009
One Force Behind The MYC Oncogene In Many Cancers Uncovered
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment